NCT03665064 2026-03-16Long Term Outcome Study in Patients With Pituitary DisordersUniversity of AlbertaActive not recruiting1,500 enrolled
NCT04042753 2025-08-08Nivolumab and Ipilimumab in People With Aggressive Pituitary TumorsMemorial Sloan Kettering Cancer CenterPhase 2 Active not recruiting9 enrolled